About CardioRisk Laboratories
Early detection of heart attacks and strokes, before it's too late. (e.g. in time to treat medically instead of waiting until a surgical intervention is your only option). CardioRisk Laboratories is a national service company offering Carotid Intima Media Thickness (CIMT) screening to primary care physicians, cardiologists, and other health care professionals and patients to help them identify and reduce cardiac, and cerebrovascular events in their patients. A CIMT test provides patients with an assessment of their individual risk for heart attack, stroke, and other ischemic events. CardioRisk provides this valuable assessment of heart attack and stroke risk at physician offices throughout the United States. We support pharmaceutical, clinical outcome, and epidemiologic studies where CIMT is used to monitor disease progression or as a surrogate for clinical events. In a 10-year, 100,000 person-year longitudinal study, IMT technology caught 98.6% of the heart attacks and strokes BEFORE they occurred. That is better than a home pregnancy test. The CardioRisk CIMT exam was scientifically designed, validated via peer-reviewed published literature demonstrating CardioRisk's unique protocol which specializes in reproducibility, sensitivity, and specificity for heart disease. The test in non-invasive, requires no radiation exposure, no disrobing is necessary and there are no needle sticks or any pain involved. Call CardioRisk to arrange to be tested in your area.
Key Facts
- Industry
- Hospitals & Clinics
- Headquarters
- Murray, Utah, United States
- Website
- cardiorisk.us
- Operating status
- Active
- Phone
- (801) 855-6775
- Specialization
- General Surgery, Emergency Room Services
Team & Specialists
Contact details of 9 CardioRisk Laboratories team members
Robert Mcdowell
Angela Alejandre
Jordann Shaffer
Michele Walters
General Emails
General company emails, e.g. customer support lines
Similar Companies like CardioRisk Laboratories
HQ: San Diego, CA
HQ: Dubai, United Arab Emirates
HQ: Minneapolis, MN
HQ: New York, NY
Frequently Asked Questions about CardioRisk Laboratories
What does CardioRisk Laboratories do?
Early detection of heart attacks and strokes, before it's too late. (e.g. in time to treat medically instead of waiting until a surgical intervention is your only option). CardioRisk Laboratories is a national service company offering Carotid Intima Media Thickness (CIMT) screening to primary care physicians, cardiologists, and other health care professionals and patients to help them identify and reduce cardiac, and cerebrovascular events in their patients. A CIMT test provides patients with an assessment of their individual risk for heart attack, stroke, and other ischemic events. CardioRisk provides this valuable assessment of heart attack and stroke risk at physician offices throughout the United States. We support pharmaceutical, clinical outcome, and epidemiologic studies where CIMT is used to monitor disease progression or as a surrogate for clinical events. In a 10-year, 100,000 person-year longitudinal study, IMT technology caught 98.6% of the heart attacks and strokes BEFORE they occurred. That is better than a home pregnancy test. The CardioRisk CIMT exam was scientifically designed, validated via peer-reviewed published literature demonstrating CardioRisk's unique protocol which specializes in reproducibility, sensitivity, and specificity for heart disease. The test in non-invasive, requires no radiation exposure, no disrobing is necessary and there are no needle sticks or any pain involved. Call CardioRisk to arrange to be tested in your area.
Where is CardioRisk Laboratories headquartered?
CardioRisk Laboratories is headquartered in Murray, Utah, United States.
What industry is CardioRisk Laboratories in?
CardioRisk Laboratories operates in the Hospitals & Clinics industry.
How do I contact CardioRisk Laboratories?
You can contact CardioRisk Laboratories via email at cardiorisk@cardiorisk.us or lorin@cardiorisk.us, headquartered in Murray, Utah, United States.